Clinical Trials Browser

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms

NCT04889937 2025-03-11

PC004

Completed

46 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT02636855 2025-03-04

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

Completed

9,122 enrolled

Other hematologic neoplasm

Neoplasm Metastasis, Neoplasms, Hematologic Neoplasms

NCT04466059 2024-12-17

BELUGA

Recruiting

25,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasm, Residual, Hematologic Neoplasms

NCT05819762 2024-12-04

Evaluation of ClearLLab LS Screening Panel

Completed

831 enrolled

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT05467449 2024-02-13

DxFLEX 10C Clinical Study

Completed

527 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT01792882 2023-02-28

GBCPRT0008

Withdrawn

BreastGastrointestinalGenitourinaryOther hematologic neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT04093622 2022-08-29

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Terminated

2 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT04264767 2022-06-08

Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

Completed

800 enrolled

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

NCT03727009 2021-02-03

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies

Terminated

409 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT03391791 2021-01-07

Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors

Terminated

2 enrolled

Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

NCT02164071 2019-11-18

GAH

Completed

363 enrolled

MyeloidOther hematologic neoplasmPlasma cell

Bronchiolitis Obliterans Syndrome, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT02842229 2017-07-26

A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

Completed

117 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT01254318 2016-11-02

TRAFIC

Completed

130 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Mycoses, Hematologic Neoplasms

NCT02188290 2015-10-06

Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation

Completed

178 enrolled

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00440479 2015-04-16

ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.

Completed

11 enrolled

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

NCT01060462 2014-05-15

Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients

Completed

438 enrolled

Other hematologic neoplasm

Fever, Neutropenia, Hematologic Neoplasms

NCT00440765 2014-01-14

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

Completed

331 enrolled

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

NCT01021683 2013-08-12

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Completed

203 enrolled 14 charts

Other hematologic neoplasm

Fever, Neutropenia, Hematologic Neoplasms

NCT01706562 2013-02-20

A Study of Empirical Antifungal Therapy With Itraconazole

Completed

138 enrolled

Classical hematologyOther hematologic neoplasm

Mycoses, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT00195533 2009-11-16

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

Completed

801 enrolled

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

Clinical Trials

PERSIST

LTFS

Aquarius

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Besponsa Post Marketing Surveillance Study

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

CARCML

SANGUINE

PC004

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

BELUGA

Evaluation of ClearLLab LS Screening Panel

DxFLEX 10C Clinical Study

GBCPRT0008

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies

Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors

GAH

A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

TRAFIC

Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation

ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.

Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

A Study of Empirical Antifungal Therapy With Itraconazole

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients